Alice Lichtenstein, Tufts University, Boston, USA, compares nutritional therapy for patients with monogenic severe hypertriglyceridaemia (SHTG), polygenic SHTG, and non-genetic secondary HTG, against a background of pancreatitis and cardiovascular risk.